Described are methods for using cyclodextrin to treat, inhibit, prevent, ameliorate, or cure diabetes or conditions relating to diabetes. More specifically, a method of the invention comprises inhibition of a cellular influx mechanism or increases a cellular efflux mechanism relating to cholesterol accumulation, including, modulation of a sphingolipid enzyme to reduce cellular cholesterol accumulation. The method can also include interference with a cellular cholesterol synthetic pathway.
